Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
about
Blockade of human group X secreted phospholipase A2 (GX-sPLA2)-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective GX-sPLA2 inhibitorInhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentPhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionHighly specific and broadly potent inhibitors of mammalian secreted phospholipases A2Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.Neuroprotective effects of a nanocrystal formulation of sPLA(2) inhibitor PX-18 in cerebral ischemia/reperfusion in gerbilsDevelopment of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A2 group IIE.A novel phospholipase A2 (D49) from the venom of the Crotalus oreganus abyssus (North American Grand canyon rattlesnake).The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced bindingHigh plasma phospholipase A2 activity, inflammation markers, and LDL alterations in obesity with or without type 2 diabetes.Formamidine hydrochloride as an amino surrogate: I2-catalyzed oxidative amidation of aryl methyl ketones leading to free (N-H) α-ketoamides.pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.
P2860
Q24622742-A4D7FD45-E496-464B-9008-EB51E28183BCQ24634492-4E0B7165-41F8-4ABD-B323-BC3C26A9E2E9Q26997377-9D4A5842-A3A1-4DAF-8CC2-3BA2D4AB607BQ34249455-62C5969C-AEF3-461D-A3C0-6F1401E6D8A7Q34632021-7051CB63-993E-4780-9367-D6DD1EF46E2AQ35590666-D7FF43C1-FCFB-4282-AB61-F1C10808581EQ36545315-CF445730-6082-4078-92B7-56A34CD5A101Q37343248-1F547160-8C20-47A5-97EC-B6530872A893Q37624745-212DD72C-D074-470D-B068-8911A88BA332Q41534911-A9D220B6-FD83-4BB3-8B15-EF190F86ABADQ42181514-91A62FD3-A9AD-478F-866D-542ACDF692FBQ42398631-B51F2061-ADB8-47B8-A651-69D05DA4AFB9Q43172296-A4EC63AE-F1B2-45ED-8E58-CAE4CF50F164Q51017882-EFE9C5C3-ED22-466A-8B46-67BF2C629A1FQ55044803-B184CA9C-F505-414F-91DA-3DDBE850AECF
P2860
Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Inhibition of the complete set ...... ues: a structure-guided study.
@ast
Inhibition of the complete set ...... ues: a structure-guided study.
@en
type
label
Inhibition of the complete set ...... ues: a structure-guided study.
@ast
Inhibition of the complete set ...... ues: a structure-guided study.
@en
prefLabel
Inhibition of the complete set ...... ues: a structure-guided study.
@ast
Inhibition of the complete set ...... ues: a structure-guided study.
@en
P2093
P1476
Inhibition of the complete set ...... ues: a structure-guided study.
@en
P2093
Amanda K Weeks
Brian J Bahnson
Brian P Smart
James G Bollinger
Ying H Pan
P304
P356
10.1016/J.BMC.2004.01.022
P407
P577
2004-04-01T00:00:00Z